The epidemiology of multiple sclerosis in Latin America and the Caribbean: a systematic review

The incidence and prevalence of multiple sclerosis (MS) varies geographically as shown through extensive epidemiological studies performed mainly in developed countries. Nonetheless, scant data is available in Latin America and the Caribbean (LAC). The objective of this review is to assess epidemiological data of MS in LAC. We conducted a systematic review of published articles and gray literature from January 1995 to May 2011. Twenty-two studies met the inclusion criteria after full-text review. Incidence data were found in only three studies and ranged from 0.3 to 1.9 annual cases per 100,000 person-years. Prevalence was reported in 10 studies and ranged from 0.83 to 21.5 cases per 100,000 inhabitants. The most prevalent subtype of MS was the relapsing–remitting form (48% to 91% of the series). No data about mortality were found. This study showed low frequency for MS in LAC compared with North American and European countries. The role of environmental and genetic factors should be well studied, providing new insights about its etiology.

[1]  Jeffrey A. Cohen,et al.  Defining the clinical course of multiple sclerosis: the 2013 revisions. , 2014, Neurology.

[2]  V. Díaz,et al.  Towards establishing MS prevalence in Latin America and the Caribbean , 2013, Multiple sclerosis.

[3]  A. B. Ortiz,et al.  Prevalencia de Esclerosis Múltiple en Lima – Perú. , 2012 .

[4]  R. Guiloff,et al.  Incidence of multiple sclerosis in Chile. A hospital registry study , 2012, Acta neurologica Scandinavica.

[5]  J. Risco,et al.  Latitudinal prevalence gradient of multiple sclerosis in Latin America , 2011, Multiple sclerosis.

[6]  Jeffrey A. Cohen,et al.  Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria , 2011, Annals of neurology.

[7]  A. Ascherio,et al.  Vitamin D and multiple sclerosis , 2010, The Lancet Neurology.

[8]  M. Pérez,et al.  Prevalencia de esclerosis múltiple en Ecuador , 2010 .

[9]  P. Sørensen,et al.  The changing demographic pattern of multiple sclerosis epidemiology , 2010, The Lancet Neurology.

[10]  E. Soriano,et al.  Incidence of multiple sclerosis in Buenos Aires: a 16‐year health maintenance organization‐based study , 2010, European journal of neurology.

[11]  A. Finkelsztejn,et al.  Clinical features of multiple sclerosis in the south of Brazil: a partial analysis. , 2009, Arquivos de neuro-psiquiatria.

[12]  J. Ioannidis,et al.  The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. , 2009, Journal of clinical epidemiology.

[13]  J. Correale,et al.  Immunomodulatory effects of Vitamin D in multiple sclerosis. , 2009, Brain : a journal of neurology.

[14]  P. Argibay,et al.  HLA‐DRB1 and multiple sclerosis in Argentina , 2009, European journal of neurology.

[15]  B. Armién,et al.  Prevalence and Incidence of Multiple Sclerosis in Panama (2000–2005) , 2009, Neuroepidemiology.

[16]  J. Correale,et al.  Prevalence of multiple sclerosis in Buenos Aires, Argentina using the capture‐recapture method , 2009, European journal of neurology.

[17]  C. Gorodezky,et al.  The HLA system in the prevalent Mexican Indian group: the Nahuas. , 2008, Tissue antigens.

[18]  E. Cristiano,et al.  A systematic review of the epidemiology of multiple sclerosis in South America , 2008, European journal of neurology.

[19]  J. Correale,et al.  Argentine Patagonia: prevalence and clinical features of multiple sclerosis , 2008, Multiple sclerosis.

[20]  G. Ebers.  Environmental factors and multiple sclerosis , 2008, The Lancet Neurology.

[21]  Y. Fragoso,et al.  Prevalence of multiple sclerosis in the city of Santos, SP , 2007 .

[22]  S. Pocock,et al.  Strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies , 2007, BMJ : British Medical Journal.

[23]  S. Pocock,et al.  The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies , 2007, The Lancet.

[24]  A. Ascherio,et al.  Environmental risk factors for multiple sclerosis. Part II: Noninfectious factors , 2007, Annals of neurology.

[25]  J. Sotelo,et al.  Western and Asian features of multiple sclerosis in Mexican Mestizos , 2007, Clinical Neurology and Neurosurgery.

[26]  C. Satizabal,et al.  Prevalence of Multiple Sclerosis in Bogotá, Colombia , 2006, Neuroepidemiology.

[27]  W. Valdar,et al.  Sex ratio of multiple sclerosis in Canada: a longitudinal study , 2006, The Lancet Neurology.

[28]  A. Melo,et al.  Clinical and epidemiological profile of multiple sclerosis in a reference center in the State of Bahia, Brazil. , 2006, Arquivos de neuro-psiquiatria.

[29]  G. Román,et al.  Multiple Sclerosis in Latin America , 2005, Neuroepidemiology.

[30]  S. Olindo,et al.  Role of return migration in the emergence of multiple sclerosis in the French West Indies. , 2005, Brain : a journal of neurology.

[31]  S. Reingold,et al.  Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria” , 2005, Annals of neurology.

[32]  T. Riise,et al.  Increasing Incidence of Multiple Sclerosis in the Province of Sassari, Northern Sardinia , 2005, Neuroepidemiology.

[33]  Maria Lucia Brito Ferreira,et al.  Epidemiologia de 118 casos de esclerose múltipla com seguimento de 15 anos no centro de referência do Hospital da Restauração de Pernambuco , 2004 .

[34]  M. Macías-Islas,et al.  [Multiple sclerosis in Mexico: a multicentre study]. , 2003, Revista de neurologia.

[35]  J. Kira.  Multiple sclerosis in the Japanese population , 2003, The Lancet Neurology.

[36]  J. Bach,et al.  The effect of infections on susceptibility to autoimmune and allergic diseases. , 2002, The New England journal of medicine.

[37]  G. Rosati,et al.  Clinical Neurology and Neurosurgery the Worldwide Prevalence of Multiple Sclerosis , 2022 .

[38]  M. Scaff,et al.  The prevalence of multiple sclerosis in the city of São Paulo, Brazil, 1997 , 2001, Acta neurologica Scandinavica.

[39]  J. Anaya,et al.  Clinical features of multiple sclerosis in a genetically homogeneous tropical population , 2001, Multiple sclerosis.

[40]  A. Compston,et al.  Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis , 2001, Annals of neurology.

[41]  W. Arruda,et al.  Multiple sclerosis: report on 200 cases from Curitiba, Southern Brazil and comparison with other Brazilian series. , 2001, Arquivos de neuro-psiquiatria.

[42]  G. Rosati,et al.  The prevalence of multiple sclerosis in the world: an update , 2001, Neurological Sciences.

[43]  M. D. Del Bigio,et al.  Aboriginals with multiple sclerosis , 2001, Neurology.

[44]  C. Aguirre,et al.  Prevalencia de la esclerosis múltiple en Colombia , 2000 .

[45]  J. Kurtzke,et al.  Epidemiology of multiple sclerosis. Does this really point toward an etiology? Lectio Doctoralis , 2000, Neurological Sciences.

[46]  I. Olkin,et al.  Meta-analysis of observational studies in epidemiology - A proposal for reporting , 2000 .

[47]  D. Spiegelman,et al.  Evaluation of old and new tests of heterogeneity in epidemiologic meta-analysis. , 1999, American journal of epidemiology.

[48]  P. López-Saura,et al.  [Alpha interferon in the treatment of multiple sclerosis. Update and experience in Cuba]. , 1999, Revista de neurología (Ed. impresa).

[49]  J. Cabrera-Gomez,et al.  [Clinical characterization of patients with multiple sclerosis defined in Cuba]. , 1998, Revista de neurología (Ed. impresa).

[50]  G. Smith,et al.  Bias in meta-analysis detected by a simple, graphical test , 1997, BMJ.

[51]  S. Reingold,et al.  Defining the clinical course of multiple sclerosis , 1996, Neurology.

[52]  F G Fowkes,et al.  Critical appraisal of published research: introductory guidelines. , 1991, BMJ.

[53]  D. P. Strachan,et al.  Hay fever, hygiene, and household size. , 1989, BMJ.

[54]  N. Laird,et al.  Meta-analysis in clinical trials. , 1986, Controlled clinical trials.

[55]  D. Silberberg,et al.  New diagnostic criteria for multiple sclerosis: Guidelines for research protocols , 1983, Annals of neurology.

[56]  T. Alarcón,et al.  [Prevalence of multiple sclerosis in Ecuador]. , 2010, Neurologia.

[57]  F. Malfetano,et al.  Multiple sclerosis outcome and morbi-mortality of a Brazilian cohort patients. , 2008, Arquivos de neuro-psiquiatria.

[58]  M. Avila,et al.  Esclerosis múltiple en Latinoamérica. ¿Son los criterios de McDonald realmente aplicables? , 2007 .

[59]  M. Ferreira,et al.  [Epidemiology of 118 cases of multiple sclerosis after 15 years of follow-up on the reference center of Hospital da Restauração, Recife, Pernambuco, Brazil]. , 2004, Arquivos de neuro-psiquiatria.

[60]  M. F. Mendes,et al.  [Multiple sclerosis: descriptive study of its clinical forms in 302 cases]. , 2000, Arquivos de neuro-psiquiatria.

[61]  T. Murray,et al.  MULTIPLE SCLEROSIS IN CHILDHOOD: CLINICAL PROFILE IN 125 PATIENTS , 1988 .